Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Bruker Nano Inc. currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 actions are assigned to 2 distinct examiners, meaning that each pending application is being reviewed by a different person. The portfolio is also spread across 2 distinct art units, which shows that each of the pending office actions is being evaluated by a different technical division.
HAQ, SHAFIQUL is the busiest examiner for the company, currently managing 1 pending office action. Since there are only 2 pending office actions in total, this single action represents half of the company's active prosecution. The fact that 2 distinct examiners are involved for the actions ensures that there is no overlap in examiner personnel for the current biotechnology and pharmaceutical portfolio.
The 2 distinct art units involved for these 2 pending office actions indicate a technical split in the company's intellectual property. Practitioners must address the specific requirements of the different art units and the distinct examiners, including HAQ, SHAFIQUL. With the pending office actions, the prosecution strategy is highly individualized for each case within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAQ, SHAFIQUL | 1 | 64.8% | +55.2% |
| NATH, SUMAN KUMAR | 1 | 82.8% | +22.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18925991 | TESTING ASSEMBLY INCLUDING A MULTIPLE DEGREE OF FREEDOM STAGE | NATH, SUMAN KUMAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19424856 | METHODS AND COMPOSITIONS FOR ENHANCED AND SELECTIVE PHOTOBLEACHING | HAQ, SHAFIQUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19424856 | METHODS AND COMPOSITIONS FOR ENHANCED AND SELECTIVE PHOTOBLEACHING | HAQ, SHAFIQUL | — |
| 18925991 | TESTING ASSEMBLY INCLUDING A MULTIPLE DEGREE OF FREEDOM STAGE | NATH, SUMAN KUMAR | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| 2855 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19424856 | METHODS AND COMPOSITIONS FOR ENHANCED AND SELECTIVE PHOTOBLEACHING | HAQ, SHAFIQUL | 1678 | §103§112 | Final Rejection | — | Pending | Dec 18, 2025 |
| 18925991 | TESTING ASSEMBLY INCLUDING A MULTIPLE DEGREE OF FREEDOM STAGE | NATH, SUMAN KUMAR | 2855 | DP | Non-Final OA | — | Pending | Oct 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBruker Nano Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Shafiqul Haq has the most, with 1 of Bruker Nano Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
